Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Dec 2008

Lowery Jan T, Byers Tim, Axell Lisen, Ku Lisa, Jacobellis Jillian

Abstract excerpt

PURPOSE: To assess the impact of direct-to-consumer marketing for genetic testing among women of varying genetic risk for breast and ovarian cancer. METHODS: Telephone surveys were conducted with 315 women in Denver, Colorado, one target audience for the Myriad BRACAnalysis ad campaign. Genetic risk was determined from personal and family history and grouped by probability of having a BRCA1/2 mutation (low <5%,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorado

Share to Genetic Counseling

Share to Genetic Testing

Share to Health Promotion

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 19092441
DOI: 10.1097/GIM.0b013e31818de6d7

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk.PMID 19092441Read ↗

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.Semantic proximity Read ↗

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.Semantic proximity Read ↗

Racial minority group interest in direct-to-consumer genetic testing: findings from the PGen studySemantic proximity Read ↗

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.Semantic proximity Read ↗

Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.Semantic proximity Read ↗

Direct-to-consumer genetic testing: An assessment of genetic counselors' knowledge and beliefsSemantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.Semantic proximity Read ↗

Consumer knowledge and opinions of genetic testing for breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.